Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...
A variety of viruses are circulating across Northeast Mississippi this winter, and their treatment differs from bacterial infections. Dr. John Cantrell, an urgent care doctor at the Fulton Medical ...
Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control ...